The groundbreaking treatment of tirzepatide peptide represents a significant development in the handling of diabetes mellitus type 2. Unlike existing drugs, tirzepatide affects two pathways – GLP-1 and GIP – https://tirzepatide-peptide882587.rimmablog.com/40708994/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment